WorldPingBetween success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT
WorldPingCapricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Brief by WorldPing · Original reporting by STAT
WorldPingMerck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Brief by WorldPing · Original reporting by NPR Health
WorldPingA new jab extended the length of time patients were cancer free, but it is unclear for how long.
Brief by WorldPing · Original reporting by BBC Health
Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.
Brief by WorldPing · Original reporting by ScienceDaily
WorldPingTap to never miss an episode: Follow Cheat Sheet here…
Brief by WorldPing · Original reporting by Sky News
WorldPingDyadic coping is a potentially modifiable protective factor in the psychological health of middle-aged and older gastrointestinal cancer survivors, according to a study recently published in the European Journal of Cancer.
Brief by WorldPing · Original reporting by Phys.org
WorldPing